Peptide Hormone News and Research

RSS
Kisspeptin and GPR54 may be the future of ovarian cancer treatment

Kisspeptin and GPR54 may be the future of ovarian cancer treatment

Low doses of a red wine ingredient resveratrol fights diabetes in mice

Low doses of a red wine ingredient resveratrol fights diabetes in mice

Researchers unlock mystery of a third olfactory system

Researchers unlock mystery of a third olfactory system

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

Pine nut oil boosts appetite suppressors

Pine nut oil boosts appetite suppressors

Australian researchers find key 'go-betweeen' in heart disease

Australian researchers find key 'go-betweeen' in heart disease

GRK5 protein plays important role in hypertension

GRK5 protein plays important role in hypertension

Naturally occurring peptide hormones - candidates for the treatment of cancer, sexual dysfunction, eating disorders

Naturally occurring peptide hormones - candidates for the treatment of cancer, sexual dysfunction, eating disorders

Nastech Pharmaceutical awarded new breast cancer patent

Nastech Pharmaceutical awarded new breast cancer patent

Myogen's Ambrisentan granted orphan drug designation by Europeans

Myogen's Ambrisentan granted orphan drug designation by Europeans

Men have a four times greater risk than women of developing abdominal aortic aneurysms

Men have a four times greater risk than women of developing abdominal aortic aneurysms

Sex hormone progesterone metabolite allopregnanolone reduces stress

Sex hormone progesterone metabolite allopregnanolone reduces stress

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension